BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 23600475)

  • 1. Dietary Mg Supplementation Decreases Oxidative Stress, Inflammation, and Vascular Dysfunction in an Experimental Model of Metabolic Syndrome with Renal Failure.
    López-Baltanás R; Rodríguez-Ortiz ME; Díaz-Tocados JM; Martinez-Moreno JM; Membrives C; Rodelo-Haad C; Pendón Ruiz de Mier MV; Rodríguez M; Canalejo A; Almadén Y; Muñoz-Castañeda JR
    Antioxidants (Basel); 2023 Jan; 12(2):. PubMed ID: 36829843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Body Fluids Biomarkers Associated With Early Neurological Deterioration Following Acute Ischemic Stroke.
    Ji X; Tian L; Yao S; Han F; Niu S; Qu C
    Front Aging Neurosci; 2022; 14():918473. PubMed ID: 35711907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between cystatin C and COPD: a meta-analysis and systematic review.
    Chai L; Feng W; Zhai C; Shi W; Wang J; Yan X; Wang Q; Zhang Q; Li M
    BMC Pulm Med; 2020 Jun; 20(1):182. PubMed ID: 32586317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C is a useful predictor of early neurological deterioration following ischaemic stroke in elderly patients with normal renal function.
    Kim TJ; Kang MK; Jeong HG; Kim CK; Kim Y; Nam KW; Mo H; An SJ; Ko SB; Yoon BW
    Eur Stroke J; 2017 Mar; 2(1):23-30. PubMed ID: 31008299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Cystatin C Levels in COPD: Potential Diagnostic Value and Relation between Respiratory Functions.
    Telo S; Kuluöztürk M; Deveci F; Kırkıl G; Öner Ö; Kaman D
    J Med Biochem; 2018 Dec; 37(4):434-440. PubMed ID: 30584402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C Expression is Promoted by VEGFA Blocking, With Inhibitory Effects on Endothelial Cell Angiogenic Functions Including Proliferation, Migration, and Chorioallantoic Membrane Angiogenesis.
    Li Z; Wang S; Huo X; Yu H; Lu J; Zhang S; Li X; Cao Q; Li C; Guo M; Lv J; Du X; Chen Z
    J Am Heart Assoc; 2018 Nov; 7(21):e009167. PubMed ID: 30571388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C as a predictor of mortality and cardiovascular events in a population with chronic kidney disease.
    Vigil A; Condés E; Vigil L; Gallar P; Oliet A; Ortega O; Rodriguez I; Ortiz M; Herrero JC; Mon C; Cobo G; Jimenez J
    Int J Nephrol; 2014; 2014():127943. PubMed ID: 24672725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C and cardiovascular or all-cause mortality risk in the general population: A meta-analysis.
    Luo J; Wang LP; Hu HF; Zhang L; Li YL; Ai LM; Mu HY; Kun-Wang
    Clin Chim Acta; 2015 Oct; 450():39-45. PubMed ID: 26192218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid Hormones, Metabolic Syndrome and Its Components.
    Delitala AP; Fanciulli G; Pes GM; Maioli M; Delitala G
    Endocr Metab Immune Disord Drug Targets; 2017; 17(1):56-62. PubMed ID: 28322173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cystatin-C levels correlate with endothelial dysfunction in patients with the metabolic syndrome.
    Balta S; Demirkol S; Ay SA; Cakar M; Sarlak H; Celik T
    J Intern Med; 2013 Aug; 274(2):200-1. PubMed ID: 23600475
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to letter to the editor 'Serum cystatin-C levels correlate with endothelial dysfunction in patients with the metabolic syndrome'.
    Magnusson M; Hedblad B; Engström G; Persson M; Nilsson P; Melander O
    J Intern Med; 2013 Nov; 274(5):496-8. PubMed ID: 23841579
    [No Abstract]   [Full Text] [Related]  

  • 12. Higher Levels of Cystatin C in HIV/AIDS Patients with Metabolic Syndrome.
    Dragović G; Srdić D; Al Musalhi K; Soldatović I; Kušić J; Jevtović D; Nair D
    Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):396-401. PubMed ID: 29024496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C: an underexplored biomarker that goes beyond renal function.
    Andrade MJ
    Rev Port Cardiol; 2014; 33(7-8):417-8. PubMed ID: 25149202
    [No Abstract]   [Full Text] [Related]  

  • 14. C-reactive protein for cardiovascular risk assessment in the metabolic syndrome: response to Kholeif et al.
    Wong ND; Malik S
    Diabetes Care; 2005 Oct; 28(10):2598-9. PubMed ID: 16186320
    [No Abstract]   [Full Text] [Related]  

  • 15. Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses.
    Magnusson M; Molvin J; Engström G; Svensson-Färbom P; Persson M; Christensson A; Nilsson P; Melander O
    PLoS One; 2016; 11(5):e0155735. PubMed ID: 27218257
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.